On Point Scientific provides medical writing services. The combination of broad medical communication expertise and a solid grounding in science allow On Point Scientific to communicate from basic science to the clinical level.
Kathy Boltz, PhD, leads On Point Scientific. As a medical writer, she has supported international physician advisory board meetings in Europe, Asia, and Australia. She has provided competitive intelligence coverage at conferences such as the American Society of Clinical Oncology (ASCO), American Society of Hematology (ASH), the European Hematology Association (EHA), and the European Lung Cancer Conference (ELCC). These projects involved working with medical affairs teams to determine sessions of interest, attending those sessions, and compiling reports of data and KOL insights.
Kathy has developed content for slide decks for branded presentations, disease state presentations, and clinical updates. She has also supported preparations for drug development advisory boards, clinical trial steering committees, and investigator meetings, and she has written summaries of these meetings for multiple pharmaceutical clients. She has written white papers, monographs, and manuscripts, along with brochures for professional audiences such as pathologists.
Kathy’s writing includes both detailed high-level scientific summaries and executive briefs from medical congresses such as ASCO, European Lung Cancer Conference (ELCC), San Antonio Breast Cancer Symposium (SABCS), American Society of Hematology (ASH), PAINWeek, Head and Neck Cancer Symposium, and Oncology Nursing Society Congress. She has produced marketing materials for campaigns for products that include Erbitux, Enbrel, Inlyta, Nplate, Prolia, Sumavel, Xeljanz, Treanda, and Yervoy. Kathy has supported additional oncology compounds and products in all phases of clinical development.
Kathy also has experience at the San Antonio Breast Cancer Symposium (SABCS), the Multidisciplinary Head and Neck Cancer Symposium, and the Oncology Nursing Society Congress. She has covered The Endocrinology Society’s Annual Meeting & Expo (ENDO), the American Academy of Dermatology Annual Meeting (AAD), PAINWeek, and the American Psychiatric Association Annual Meeting (APA).
Kathy has regularly contributed to Oncology Business Review, covering topics that include the physician experience at ASCO, liquid biopsies, biomarkers, analyses of drug development costs, value tools from ASCO and NCCN, patient support philanthropies, genomics in pediatric cancer, and consolidation of the NCI cooperative groups. Further, Kathy’s oncology business writing with OBR includes an extensive e-learning series on the business of oncology, whose modules include federal and commercial payers, managed care organizations, oncology drug reimbursement, group purchasing organizations, clinical guidelines and clinical pathways, quality and value in oncology management, the cancer patient, and personalized medicine, among other topics. She also has written about value and cost in oncology, and how biomarkers tie in to the business of oncology.
Why the dog logo? When a German short-haired pointer is in the field, his eyes, ears, and, most importantly, nose are all tuned in to collect massive amounts of data, sort through the noise, make sense of it all, and point to his target. Kathy takes in scientific data and communicates it in a way that are targeted to her clients’ needs, focusing on the most relevant concepts and pulling together data to get to the point of the communication. By the way, Kathy doesn’t actually hunt with her pointer, but they enjoy long mountain bike rides together as often as possible, and he’s usually pointing out whatever critters are there along the trails.